Anti-TNF Agents are Changing the Natural History of Crohn's Disease

被引：0
|
作者：
Fu, Yi-Tzu Nancy
Hong, Thomas
Qian, Hong
Bressler, Brian
机构：
来源：
GASTROENTEROLOGY | 2012年 / 142卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S779 / S779
页数：1
相关论文
共 50 条
  • [41] Comparative Effectiveness of Anti-TNF Agents for Crohn’s Disease in a Tertiary Referral IBD Practice
    Seema A. Patil
    Ankur Rustgi
    Patricia Langenberg
    Raymond K. Cross
    Digestive Diseases and Sciences, 2013, 58 : 209 - 215
  • [42] AMISELIMOD SAFETY PROFILE FOR CROHN'S DISEASE, STRATIFIED BY PREVIOUS TREATMENT WITH ANTI-TNF AGENTS
    D'Haens, Geert R. A. M.
    Slatkin, Neal
    Israel, Robert
    Heimanson, Zeev
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S1 - S1
  • [43] Agalactosyl IgG predicts therapeutic effect of anti-TNF agents in patients with Crohn's Disease
    Araki, M.
    Shinzaki, S.
    Iijima, H.
    Yamaguchi, T.
    Kawai, S.
    Hiyama, S.
    Inoue, T.
    Hayashi, Y.
    Watabe, K.
    Tsujii, M.
    Miyoshi, E.
    Takehara, T.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S259 - S260
  • [44] Azathioprine versus mycophenolate mofetil in combination with anti-TNF alpha agents in the management of Crohn's disease
    Eigner, W.
    Vafai-Tabrizi, F.
    Bashir, K.
    Primas, C.
    Vogelsang, H.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S326 - S326
  • [45] Utilisation of anti-TNF agents in phlegmonous Crohn's disease: an Australian tertiary referral centre experience
    Chiu, L.
    Digby-Bell, J.
    Seah, J.
    Melton, S.
    Taylor, K.
    Sparrow, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S542 - S543
  • [46] Comparative Effectiveness and Safety of Anti-TNF Agents for Crohn's Disease in Biologic-Naive Patients
    Singh, Siddharth
    Sangaralingham, Lindsey R.
    Heien, Herbert
    Anderson, Stephanie S.
    Shah, Nilay
    Loftus, Edward V.
    GASTROENTEROLOGY, 2015, 148 (04) : S175 - S175
  • [47] Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis
    Eros, Adrienn
    Farkas, Nelli
    Hegyi, Peter
    Szabo, Aniko
    Balasko, Marta
    Veres, Gabor
    Czako, Laszlo
    Bajor, Judit
    Alizadeh, Hussain
    Rakonczay, Zoltan
    Miko, Alexandra
    Habon, Tamas
    Eross, Balint
    Berczi, Balint
    Sarlos, Patricia
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (08) : 1086 - 1095
  • [48] How to Manage Loss of Response to Anti-TNF in Crohn's Disease?
    Reinisch, Walter
    CURRENT DRUG TARGETS, 2010, 11 (02) : 152 - 155
  • [49] Anti-TNF Alpha Therapy and Orofacial Crohn's Disease in Pediatrics
    Chapuy, Laurence
    Deslandres, Colette
    INFLAMMATORY BOWEL DISEASES, 2012, 18 : S71 - S71
  • [50] Impact analysis of expanding anti-TNF therapy for Crohn's disease
    Honeycutt, Amanda
    Breck, Andrew
    Bass, Sarah
    Esposito, Dominick
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (02) : 79 - 88
12345